SimCorp A/S
Company Announcement no. 07/2021
On February 10, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR.
In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 10, 2021 to July 31, 2021.
The following transactions have been executed under the program:
| Date | Number of shares | Average purchase price (DKK per share) | Amount (DKK) |
| Accumulated under the program as of last announcement: | 41,900 | 787.14 | 32,981,225 |
| March 1, 2021 | 3,500 | 755.53 | 2,644,355 |
| March 2, 2021 | 3,500 | 761.86 | 2,666,510 |
| March 3, 2021 | 4,000 | 747.15 | 2,988,600 |
| March 4, 2021 | 4,000 | 724.74 | 2,898,960 |
| March 5, 2021 | 4,000 | 719.28 | 2,877,120 |
| Accumulated under the program following above purchases: | 60,900 | 772.69 | 47,056,770 |
Following above purchases, SimCorp holds 762,587 treasury shares corresponding to 1.9% of the share capital.
Purchases for an amount of EUR 13.7m (approx. DKK 101.7m) remain to be executed under the program.
Enquiries regarding this announcement should be addressed to:
Anders Hjort, Head of Investor Relations, SimCorp A/S (+45 3544 8822)
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd8.11.2025 00:00:00 CET | Press release
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
Columbus A/S7.11.2025 23:46:30 CET | Press release
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Evaxion7.11.2025 23:10:00 CET | Press release
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
VALLOUREC7.11.2025 18:45:00 CET | Press release
VALLOUREC ANNOUNCES A TRANSITION IN ITS FINANCIAL MANAGEMENT
Trifork Group AG7.11.2025 18:29:08 CET | Press release
52/2025・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
